ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

PBS’s Documentary ‘The Gene Doctors’ Arrives Amid A Gene – Forbes – Forbes

Continue reading

2017-10-19 Michael Zand NEWS

UChicago Medicine first site in Illinois offering pioneering CAR T-cell therapy for cancer – EurekAlert (press release)

EurekAlert (press release)UChicago Medicine first site in Illinois offering pioneering CAR T-cell therapy for cancerEurekAlert (press release)The treatment, known as CAR T-cell therapy, is being offered by the University of Chicago Medicine, the first … Continue reading

2017-10-19 Michael Zand NEWS

Pioneer to bring CRISPR-Cas technology to Danforth Center … – AGDAILY

AGDAILYPioneer to bring CRISPR-Cas technology to Danforth Center …AGDAILYDuPont Pioneer is bringing CRISPR-Cas technology to the Danforth Center to jointly develop improved food security crops.and more &raquo… Continue reading

2017-10-19 Michael Zand NEWS

Stem cell platform sheds new light on beginnings of human development – Phys.Org

Stem cell platform sheds new light on beginnings of human developmentPhys.OrgBelieved to be the first of its kind in Canada, the technology enables human embryonic stem cells to self-organize into a structure with embryo-like features, including the ea… Continue reading

2017-10-19 Michael Zand NEWS

FDA Approves CAR T-Cell Therapy for Non-Hodgkin Lymphoma – www.oncnursingnews.com/


Forbes

PBS’s Documentary ‘The Gene Doctors’ Arrives Amid A Gene – Forbes
Forbes
A new PBS film educates viewers about gene therapy at a time when the once controversial field of research is starting to bear fruit.
First-of-Its-Kind Gene Therapy Could Treat BlindnessHealthline

all 5 news articles »

Continue reading

2017-10-19 Michael Zand NEWS

CRISPR Therapeutics Receives FARA Grant to Develop Gene Editing Therapies for Friedreich’s Ataxia – Friedreich’s Ataxia News

FDA Approves CAR T-Cell Therapy for Non-Hodgkin Lymphoma
www.oncnursingnews.com/
The FDA has approved the CD19-directed CAR T-cell therapy axicabtagene ciloleucel (axi-cel; Yescarta) for people with large B-cell lymphoma following 2 prior therapies, including for those with diffuse large B-cell lymphoma (DLBCL). It is also …
FDA Approves Yescarta™, Revolutionary CAR–T Immunotherapy for Non-Hodgkin’s Lymphoma PatientsPR Newswire (press release)
FDA Approves Axi-Cel for Large B-cell LymphomaTargeted Oncology

all 2 news articles »

Continue reading

2017-10-19 Michael Zand NEWS

Dutch Biotech plans Pivotal Clinical Trial with First Gene Therapy for Hemophilia – Labiotech.eu (blog)

Dutch Biotech plans Pivotal Clinical Trial with First Gene Therapy for HemophiliaLabiotech.eu (blog)uniQure is getting ready to start a Phase III clinical trial in 2018 with a new version of its gene therapy for hemophilia B. uniQure has officially lau… Continue reading

2017-10-19 Michael Zand NEWS

Dutch Biotech plans Pivotal Clinical Trial with First Gene Therapy for Hemophilia – Labiotech.eu (blog)

Dutch Biotech plans Pivotal Clinical Trial with First Gene Therapy for HemophiliaLabiotech.eu (blog)uniQure is getting ready to start a Phase III clinical trial in 2018 with a new version of its gene therapy for hemophilia B. uniQure has officially lau… Continue reading

2017-10-19 Michael Zand NEWS
  • 1
  • …
  • 1,026
  • 1,027
  • 1,028
  • 1,029
  • 1,030
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Friedreich’s Ataxia News

CRISPR Therapeutics Receives FARA Grant to Develop Gene Editing Therapies for Friedreich’s Ataxia
Friedreich’s Ataxia News
“We believe that the combination of CRISPR’s pioneering gene-editing capabilities with Dr. Marek Napierala’s deep expertise in FA may accelerate the development of new therapies for FA,” Jennifer Farmer, FARA’s executive director, said in a press release.